FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals. First object is a stable liquid composition containing (1) a botulinum toxin, (2) L-alanine or methyl cellulose, (3) a nonionic surfactant which is polysorbate 20 or polysorbate 80, and (4) a buffer, as well as an additionally containing isotonic agent. Second object is a method for stabilizing botulinum toxin using a liquid composition.
EFFECT: technical result consists in stability of the developed liquid composition of botulinum toxin.
9 cl, 7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS OF CLOSTRIDIA TOXIN | 2009 |
|
RU2535003C2 |
| LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
| LIQUID COMPOSITION OF LONG-ACTING ALPHA INTERFERON CONJUGATE | 2011 |
|
RU2613905C2 |
| LIQUID FORMULATIONS FOR LONG-ACTING CONJUGATE OF G-CSF | 2011 |
|
RU2519031C1 |
| LIQUID COMPOSITION STABILIZING BOTULINUM TOXIN | 2019 |
|
RU2812790C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2737264C2 |
| PREPARATION FOR TREATMENT OF MUSCULAR DYSTONIA FROM TOXIN OF CULTURE CLOSTRIDIUM BOTULINUM AND METHOD FOR ITS PREPARING | 2004 |
|
RU2255761C1 |
| LIQUID PHARMACEUTICAL COMPOSITION OF BOTULINUM TOXIN | 2008 |
|
RU2440825C2 |
| Liquid composition containing botulinum toxin and a stabilizing agent, and a method for its preparation | 2017 |
|
RU2748653C2 |
